$ALDX News Article - Aldeyra Therapeutics Receives Complete Response Letter from the U.S. Food and Drug Administration for the Reproxalap New Drug Application for the Treatment of Dry Eye Disease
https://marketwirenews.com/news-releases/alde...92169.html